Description
Ipamorelin Peptide Description
Ipamorelin is a highly selective Growth Hormone Secretagogue (GHS) consisting of five amino acids (Aib-His-D-2Nal-D-Phe-Lys). Developed as a synthetic ghrelin receptor agonist, Ipamorelin has become one of the most widely researched peptides for investigating natural growth hormone release, muscle recovery, metabolic regulation, and tissue regeneration.
Unlike earlier growth hormone-releasing peptides, Ipamorelin demonstrates exceptional selectivity for the Growth Hormone Secretagogue Receptor (GHS-R1a). Laboratory studies suggest it stimulates pulsatile growth hormone release while having minimal influence on other pituitary hormones such as cortisol, prolactin, ACTH, or thyroid hormones. This selective mechanism has made Ipamorelin a valuable research peptide for studying growth hormone physiology and endocrine signaling.
Researchers have extensively investigated Ipamorelin for its role in activating the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) axis. Experimental models suggest increased GH secretion may support protein synthesis, muscle development, tissue repair, collagen production, and healthy body composition while promoting normal metabolic function.
Additional research has explored Ipamorelin’s potential effects on bone remodeling, nitrogen retention, gastric motility, and fat metabolism. Laboratory findings indicate the peptide may enhance bone mineral content, improve recovery following catabolic states, stimulate cellular regeneration, and promote lipolysis through growth hormone-mediated pathways.
Because of its receptor specificity and predictable pharmacological profile, Ipamorelin continues to be one of the most popular peptides in longevity, regenerative medicine, and performance-related laboratory research.
Ipamorelin Peptide Benefits
Research suggests Ipamorelin may support:
- Natural growth hormone release
- Increased IGF-1 production
- Lean muscle development
- Fat metabolism and body composition
- Muscle recovery after exercise
- Tissue repair and regeneration
- Collagen synthesis
- Bone health and bone mineral density
- Improved sleep quality
- Healthy metabolic function
- Nitrogen retention and protein synthesis
- Cellular recovery and regeneration
Ipamorelin Peptide Dosage
Common research protocols reference:
- Dosage: 200-300 mcg per injection
- Frequency: 1-3 injections daily
- Administration: Subcutaneous injection
- Cycle Length: 8-12 weeks is commonly referenced in research settings.
Ipamorelin Peptide Information
| Property | Value |
|---|---|
| Peptide Sequence | Aib-His-D-2Nal-D-Phe-Lys-NH₂ |
| Molecular Formula | C38H49N9O5 |
| Molecular Weight | 711.86 g/mol |
| CAS Number | 170851-70-4 |
| PubChem CID | 9831659 |
| Synonyms | Ipamorelin, NNC-26-0161, GHRP, Growth Hormone Secretagogue |
Ipamorelin Peptide Effects
Laboratory and preclinical research suggests Ipamorelin may support the investigation of:
- Increased natural growth hormone (GH) release
- Enhanced IGF-1 production pathways
- Lean muscle development and protein synthesis
- Fat metabolism and lipolysis
- Recovery and tissue repair mechanisms
- Collagen synthesis and connective tissue remodeling
- Bone mineral density and skeletal health
- Cellular regeneration and wound-healing pathways
- Improved nitrogen retention during catabolic states
- Gastric emptying and gastrointestinal motility
- Growth hormone receptor signaling
- Healthy aging and metabolic regulation
While these findings are promising, they remain under active scientific investigation and should not be interpreted as established clinical outcomes.
